Development of a butyrate metabolism-related gene-based molecular subtypes and scoring system for predicting prognosis and immunotherapy response in bladder cancer-Reference-Cited by-同舟云学术

Development of a butyrate metabolism-related gene-based molecular subtypes and scoring system for predicting prognosis and immunotherapy response in bladder cancer

Published:2023-07-14 Issue:13 Volume:149 Page:12489-12505
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Yuan Peng,Li Sheng,Xiong Situ,Zheng Fucun,Yang Lin,Jiang Ming,Liu Jiahao,Liu Xiaoqiang,Deng Jun,Zeng Jin,Fu Bin

Funder

Project of Natural Science Foundation of Jiangxi Province

Jiangxi Provincial “Double Thousand Plan” Fund Project

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-05067-5.pdf

Reference39 articles.

1. Alifrangis C, McGovern U, Freeman A, Powles T, Linch M (2019) Molecular and histopathology directed therapy for advanced bladder cancer. Nat Rev Urol 16(8):465–483. https://doi.org/10.1038/s41585-019-0208-0

2. DeNardo DG, Ruffell B (2019) Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol 19(6):369–382. https://doi.org/10.1038/s41577-019-0127-6

3. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504(7480):446–450. https://doi.org/10.1038/nature12721

4. Ghos Cisplatin S (2019) The first metal based anticancer drug. Bioorg Chem 88:102925. https://doi.org/10.1016/j.bioorg.2019.102925

5. Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV et al (2018) Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science 359(6371):97–103. https://doi.org/10.1126/science.aan4236